• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MHC I类配体的生化大规模鉴定

Biochemical large-scale identification of MHC class I ligands.

作者信息

Kowalewski Daniel J, Stevanović Stefan

机构信息

Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.

Department of Immunology, University of Tübingen, Interfaculty Institute for Cell Biology, Tübingen, Germany.

出版信息

Methods Mol Biol. 2013;960:145-157. doi: 10.1007/978-1-62703-218-6_12.

DOI:10.1007/978-1-62703-218-6_12
PMID:23329485
Abstract

The large-scale identification of MHC class I presented peptides is indispensable for gaining insight into the fundamental rules of immune recognition as well as it is an invaluable tool in identifying potential targets for the immunotherapy of disease. In this chapter we briefly review the existing strategies for the analysis of MHC ligandomes and provide an in-depth protocol for the immunoaffinity purification of MHC class I presented peptides from primary tissues or cells.

摘要

大规模鉴定主要组织相容性复合体(MHC)I类呈递的肽段,对于深入了解免疫识别的基本规则必不可少,同时也是确定疾病免疫治疗潜在靶点的宝贵工具。在本章中,我们简要回顾了分析MHC配体组的现有策略,并提供了从原代组织或细胞中免疫亲和纯化MHC I类呈递肽段的详细方案。

相似文献

1
Biochemical large-scale identification of MHC class I ligands.MHC I类配体的生化大规模鉴定
Methods Mol Biol. 2013;960:145-157. doi: 10.1007/978-1-62703-218-6_12.
2
Purification and Identification of Naturally Presented MHC Class I and II Ligands.天然呈递的MHC I类和II类配体的纯化与鉴定
Methods Mol Biol. 2019;1988:123-136. doi: 10.1007/978-1-4939-9450-2_10.
3
Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines.从癌细胞系中纯化和鉴定 MHC Ⅰ类免疫肽组的方案。
STAR Protoc. 2021 Mar 18;2(1):100385. doi: 10.1016/j.xpro.2021.100385. eCollection 2021 Mar 19.
4
Critical Review of Existing MHC I Immunopeptidome Isolation Methods.现有 MHC I 免疫肽组分离方法的批判性评价。
Molecules. 2020 Nov 19;25(22):5409. doi: 10.3390/molecules25225409.
5
Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics.基于质谱的 MHC 结合肽鉴定用于免疫肽组学。
Nat Protoc. 2019 Jun;14(6):1687-1707. doi: 10.1038/s41596-019-0133-y. Epub 2019 May 15.
6
Improving MHC-I Ligand Identification by Incorporating Targeted Searches of Mass Spectrometry Data.通过整合质谱数据的靶向搜索来提高 MHC-I 配体鉴定。
Methods Mol Biol. 2020;2120:161-171. doi: 10.1007/978-1-0716-0327-7_11.
7
Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome.轻度酸洗脱和 MHC 免疫亲和色谱法揭示了 HLA I 类免疫肽组相似但不完全相同的特征。
J Proteome Res. 2021 Jan 1;20(1):289-304. doi: 10.1021/acs.jproteome.0c00386. Epub 2020 Nov 3.
8
Mass Spectrometry Based Immunopeptidomics for the Discovery of Cancer Neoantigens.基于质谱的免疫肽组学用于发现癌症新抗原。
Methods Mol Biol. 2018;1719:209-221. doi: 10.1007/978-1-4939-7537-2_14.
9
Comprehensive analysis of MHC ligands in clinical material by immunoaffinity-mass spectrometry.通过免疫亲和质谱法对临床材料中的MHC配体进行综合分析。
Methods Mol Biol. 2013;1023:203-18. doi: 10.1007/978-1-4614-7209-4_14.
10
Extending the Comprehensiveness of Immunopeptidome Analyses Using Isobaric Peptide Labeling.采用等压肽标记技术扩展免疫肽组分析的全面性。
Anal Chem. 2020 Jul 7;92(13):9194-9204. doi: 10.1021/acs.analchem.0c01545. Epub 2020 Jun 23.

引用本文的文献

1
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics.基于整合多组学技术绘制髓母细胞瘤中自然呈现的T细胞抗原图谱。
Nat Commun. 2025 Feb 4;16(1):1364. doi: 10.1038/s41467-025-56268-0.
2
Myeloid cell MHC I expression drives CD8 T cell activation in nonalcoholic steatohepatitis.髓系细胞MHC I表达驱动非酒精性脂肪性肝炎中CD8 T细胞的激活。
Front Immunol. 2024 Jan 11;14:1302006. doi: 10.3389/fimmu.2023.1302006. eCollection 2023.
3
Identification and relative abundance of naturally presented and cross-reactive influenza A virus MHC class I-restricted T cell epitopes.
鉴定和相对丰度的天然呈现和交叉反应的流感 A 病毒 MHC Ⅰ类限制性 T 细胞表位。
Emerg Microbes Infect. 2024 Dec;13(1):2306959. doi: 10.1080/22221751.2024.2306959. Epub 2024 Feb 8.
4
Targeting of intracellular oncoproteins with peptide-centric CARs.针对细胞内癌蛋白的肽段 CAR 靶向治疗。
Nature. 2023 Nov;623(7988):820-827. doi: 10.1038/s41586-023-06706-0. Epub 2023 Nov 8.
5
Peptide-based vaccine for cancer therapies.基于肽的癌症治疗疫苗。
Front Immunol. 2023 Aug 16;14:1210044. doi: 10.3389/fimmu.2023.1210044. eCollection 2023.
6
The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination.口咽鳞状细胞癌的 HLA 配体组揭示了用于半个性化疫苗接种的共享肿瘤特异性肽。
Br J Cancer. 2023 May;128(9):1777-1787. doi: 10.1038/s41416-023-02197-y. Epub 2023 Feb 23.
7
T cells of colorectal cancer patients' stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells.结直肠癌患者的 T 细胞经新抗原和隐匿肽刺激后,能更好地识别自体肿瘤细胞。
J Immunother Cancer. 2022 Dec;10(12). doi: 10.1136/jitc-2022-005651.
8
Antigen presentation safeguards the integrity of the hematopoietic stem cell pool.抗原呈递保障了造血干细胞库的完整性。
Cell Stem Cell. 2022 May 5;29(5):760-775.e10. doi: 10.1016/j.stem.2022.04.007.
9
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.利用基于肽的嵌合抗原受体对细胞内癌蛋白进行 HLA 交叉靶向。
Nature. 2021 Nov;599(7885):477-484. doi: 10.1038/s41586-021-04061-6. Epub 2021 Nov 3.
10
Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair-deficient colorectal cancer tissue.错配修复缺陷型结直肠癌组织中免疫原性 HLA Ⅰ类新抗原的蛋白质基因组学鉴定。
JCI Insight. 2021 Jul 22;6(14):e146356. doi: 10.1172/jci.insight.146356.